8/1/2025 11:16:44 AM CMA begins to take action on Fake Reviews By Rob Powell New rules which aim to crack down on the problem of fake or misleading reviews online came into force back in April 2025, as part of the...
8/1/2025 9:01:18 AM EU AI Act - General Purpose AI Code of Practice compliance tools published ahead of 2 August deadline By Vik Khurana Charlie Hawes Sebastian Stewart Camille Beckmann +1 more... Show less What is the General-Purpose AI (GPAI) Code of Practice? On 10 July, the EU Commission published the fourth and final version of the GPAI...
7/31/2025 4:18:29 PM PISCES: A Sea-Change for Scale Ups By James Johnston The UK is launching a new regulatory framework known as PISCES (Public Intermittent Securities and Capital Exchange System) to enable the...
7/31/2025 12:19:00 PM Generative AI in context of copyright: knowing your hypersurfaces from your stochastic parrots By Toby Headdon The European Parliament’s Policy Department for Justice, Civil Liberties and Institutional Affairs has prepared a briefing entitled...
7/31/2025 11:40:38 AM Bristows’ SnippITs - The importance of “splitting hairs” in your settlement agreements: Zaloumis v Steele By Freya Ollerearnshaw Helin Kaya This post is the latest in the Bristows’ SnippITs series, which pulls together the key practical takeaways from recent court decisions...
7/31/2025 8:51:24 AM The double-edged sword of AI in femtech in the EU By Ellie Handy Subhalakshmi Kumar Kiran Sidhu AI presents many opportunities in the women’s health space, but it can also pose considerable risks. Anyone seeking to commercialise...
7/30/2025 3:01:07 PM It’s time to act on the new R&D regime By Julia Cockroft Tabitha Reed Although the UK’s new R&D tax relief regime came into force on 1 April 2024, many companies have only now completed their first...
7/30/2025 2:34:53 PM Biotech Review of the Year: latest developments By Bristows LLP At the start of the year, our editors (Xisca Borrás, Katie Cambrook and Aida Tohala) presented to you the 12th edition of our Biotech...
7/30/2025 10:54:35 AM Sarepta’s Duchenne difficulties: potential implications for gene therapy licensing By Ellen Lambrix Luca Cericola Earlier this year, we reported on key considerations that parties involved in the negotiation and drafting of financial milestone...
7/28/2025 8:53:52 AM Irides: Weekly patent litigation update By Gregory Bacon Richard Pinckney Maria Ryan Nicholas Round Eden Winlow +2 more... Show less This edition features updates from: Denmark, Germany, Brazil and the Unified Patent Court (UPC). The Irides Weekly Update is our round-up...
7/25/2025 9:19:27 AM Court of Appeal upholds Astellas' enzalutamide patent By Claire Phipps-Jones On Wednesday, the Court of Appeal handed down a decision upholding Astellas’ enzalutamide patent. Appeals on the question of obviousness...
7/25/2025 8:54:32 AM Licensing Executives Society Britain & Ireland 2025 Annual Conference: Licensing as a solution in an age of uncertainty By Ellen Lambrix Luca Cericola Earlier this month, Ellen Lambrix and Luca Cericola from Bristows’ Commercial & IP Transactions team attended the Licensing Executives...